SABBY MANAGEMENT LLC 13D and 13G filings for BiondVax Pharmaceuticals Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-03 6:16 pm Sale |
2024-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 29,051 4.900% |
-191,612 (-86.83%) |
Filing |
| 2024-01-02 4:54 pm Sale |
2023-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 220,663 11.000% |
-7,666 (-3.36%) |
Filing |
| 2023-01-04 09:21 am Purchase |
2022-12-31 | 13G | BiondVax Pharmaceuticals Ltd. BVXV |
SABBY MANAGEMENT LLC | 228,329 11.000% |
228,329 (New Position) |
Filing |